BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1335 related articles for article (PubMed ID: 19762155)

  • 1. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
    Petersen LJ
    Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
    Merli GJ
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
    Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
    Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of deep vein thrombosis in cancer patients.
    Lee AY
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis and treatment of venous thromboembolism in cancer patients: a review.
    Ansell JE
    Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S8-S12. PubMed ID: 19654482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
    Rhodes S; Bond S
    Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
    Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
    Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
    Khorana AA
    Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated venous thrombosis in the surgical setting.
    Behranwala KA; Williamson RC
    Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unanswered questions in venous thromboembolism.
    Weitz JI
    Thromb Res; 2009; 123 Suppl 4():S2-S10. PubMed ID: 19303498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thoughts about thromboembolic events prophylaxis in cancer patients].
    Pikó B; Kremer IM; Rahoty P; Bassam A; Dimák S; Kis A; Csiffári M; Rus-Gal P; Szabó Z; Veréb B; Zsilak J
    Magy Onkol; 2011 Sep; 55(3):164-9. PubMed ID: 21918741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in cancer patients undergoing major surgery.
    Osborne NH; Wakefield TW; Henke PK
    Ann Surg Oncol; 2008 Dec; 15(12):3567-78. PubMed ID: 18841419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of venous thromboembolism in cancer patients.
    Petralia GA; Kakkar AK
    Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of venous thromboembolism during pregnancy.
    Weitz JI
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S22-6. PubMed ID: 19213066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
    Cohen AT; Nandini B; Wills JO; Ota S
    Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VTE in patients with cancer--diagnosis, prevention, and treatment.
    Lee A
    Thromb Res; 2008; 123 Suppl 1():S50-4. PubMed ID: 18824256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism in the medically ill patient: a call to action.
    Bergmann JF; Kher A
    Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of venous thromboembolism and the potential to impact overall survival in patients with cancer.
    Saraiya B; Goodin S
    Pharmacotherapy; 2009 Nov; 29(11):1344-56. PubMed ID: 19857150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.